Multicenter Study on the Efficacy, Safety and Pharmacokinetics of Leuprolide Acetate 45 mg.


Clinical Trial

Offered by: Nemours
Location: Orlando, Fla.

Trial Name

An Open-Label, Single Arm, Multicenter Study on the Efficacy, Safety and Pharmacokinetics of Leuprolide Acetate 45 mg., for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty.

What is the trial about?

The purpose of this study is to determine the safety and effectiveness of the new form of leuprolide acetate for children with central precocious puberty.

Who can participate?

Girls 2–8 years and Boys 2–9 years with central precocious puberty.

What is involved?

Nine visits to Nemours Children’s Hospital over one year. Procedures and tests to be done include physical exam, X-rays, blood and urine samples, hormone stimulation test and pregnancy test.

Contact Nemours Clinical Trials

Trial Name: An Open-Label, Single Arm, Multicenter Study on the Efficacy, Safety and Pharmacokinetics of Leuprolide Acetate 45 mg., for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty.

Contact Information

(800) 354-5690
ClinicalTrials@nemours.org